| 영문 | shock | 한글 | 쇼크, 충격 |
|---|---|---|---|
| 설명 | 1. 정신적 평형의 돌연한 장애. 2. 어떠한 원인으로 진행성인 말초순환부족의 결과로 조직의 산소부족증을 일으켜 탄산가스나 유산등의 대사산물의 축적을 일으킨 상태를 말한다. 쇼크의 임상증상은 ① 피부의 창백, ② 손발톱모세혈관의 재충만 지연, ③ 의식장애, ④ 혈압하강, 맥박긴장저하, ⑤ 요량감소 등이다. 쇼크의 분류에는 1차성쇼크, 2차성쇼크가 있으며 순환동태에 의한 분류로서 저혈류량성쇼크, 말초혈관확장성쇼크, 심장성쇼크가 있다. 병인적인 분류로서 신경탓쇼크, 아나피락시스쇼크, 국소마취약 중독의 결과로 일어나는 쇼크 등이 있다. |
||
| 영문 | heart-lung machine | 한글 | 심장-허파 기계 |
|---|---|---|---|
| 설명 | 심장의 수술에 사용되는 기계로서 심장이 수술을 받고 있는 동안 기능을 하지 못하므로 이 기능을 대신 해주는 기계이다. 이것은 대정맥과 대동맥사이에 연결이 되어서 혈액을 강제로 순환시키면서 대정맥에서 온 피에 산소를 공급하여 대동맥으로 돌려 보내는 역할을 한다. 즉 심장과 폐의 역할을 동시에 하는 기계이다. |
||
| 영문 | total lung capacity | 한글 | 전폐용량, 온허파용량 |
|---|---|---|---|
| 설명 | 폐활량(가능한 한 깊게 들여 마신 시점부터 천천히 한껏 내쉰 용량)에 잔기량(최대 날숨위치에서 폐내에 남은 용량. 약 1,200mL)을 합한 것이다. 건강한 성인은 6,000~7,000mL. 폐기종, 만성 기관지염 등의 폐색성 장애로 증가하게 되는 한편 허파섬유증, 무기폐, 흉수, 흉곽변형 등의 구속성 장애로 감소한다. |
||
| 영문 | lung cancer | 한글 | 폐암 |
|---|---|---|---|
| 설명 | 허파에 생기는 악성종양이다. 가장 예후가 나쁜 종양중의 하나로써 조기발견이 어렵고 증세 또한 늦게 나타나서, 그 종양의 종류에 따라 다르나 치료후에도 대개 8%만이 5년 생존이 가능한 악성종양이다. 유발인자로는 대표적으로 담배가 알려져 있으며, 유전적인 요소도 어느 정도 기여하는 것으로 알려져 있다. |
||
| DILD | diffuse infiltrative lung disease; diffuse interstitial lung disease |
|---|---|
| LC | Laennec cirrhosis; Langerhans cell; late clamped; large chromophobe; lecithin cholesterol acyltransf... |
| TLC | tender loving care; thin-layer chromatography; total L-chain concentration; total lung capacity; tot... |
| AMI | Acute Myocardial Infarction - Complications(Cx) 1. Early ... |
| DSS | 1) Double Simultaneous Stimulation 2) Dengue Shock Syndrome |
| HSP | 2)/heat shock protein |
|---|---|
| ESWL | 2--extracorporeal shock-wave lithotripsy |
| CS | Cardiogenic shock |
| CSD | Cold shock domain |
| CSP | cold shock protein |
| shock lung | In shock, the development of oedema, impaired perfusion, and reduction in alveolar space so that the alveoli collapse. Synonym: pump lung, wet lung, white lung. (05 Mar 2000) |
|---|
| anaesthetic shock | Shock produced by the administration of anaesthetic drug(s), usually in relative overdosage. (05 Mar 2000) |
|---|---|
| anaphylactic shock | <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing. (27 Sep 1997) |
| anaphylactoid shock | A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions. Synonym: anaphylactoid crisis, pseudoanaphylactic shock. (05 Mar 2000) |
| break shock | The shock produced by breaking a constant current passing through the body. (05 Mar 2000) |
| cardiac shock | A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy. Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully. (27 Sep 1997) |
| cardiogenic shock | A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy. Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully. (27 Sep 1997) |
| cardiopulmonary obstructive shock | <cardiology> This term describes a number of conditions that involve a severe disturbance of the cardiopulmonary circuit resulting in shock (inadequate delivery of oxygen to the tissues). Examples include: pulmonary embolism, pericardial tamponade, pneumothorax and constrictive pericarditis. (27 Sep 1997) |
| vasogenic shock | Shock resulting from depressed activity of the higher vasomotor centres in the brain stem and the medulla, producing vasodilation without loss of fluid so that the container is disproportionately large. In oligaemic shock, blood volume is reduced; in both, return of venous blood is inadequate. (05 Mar 2000) |
| reversible shock | Shock that will respond to treatment and from which recovery is possible. (05 Mar 2000) |
| chronic shock | The state of peripheral circulatory insufficiency developing in elderly patients with a debilitating disease, e.g., carcinoma; a subnormal blood volume makes the patient susceptible to haemorrhagic shock as a result of even a moderate blood loss such as may occur during an operation. (05 Mar 2000) |
| wet shock | A severe condition that occurs when the level of blood glucose (sugar) drops quickly. The signs are shaking, sweating, dizziness, double vision, convulsions, and collapse. Insulin shock may occur when an insulin reaction is not treated quickly enough. See: hypoglycaemia. (09 Oct 1997) |
| cultural shock | A form of stress associated with the beginning of an individual's assimilation into a new culture vastly different from that in which he or she was raised. (05 Mar 2000) |
| haemorrhagic shock | Hypovolaemic shock resulting from acute haemorrhage, characterised by hypotension, tachycardia, pale, cold, and clammy skin, and oliguria. (05 Mar 2000) |
| primary shock | Shock mainly nervous in nature, from pain, anxiety, etc., which ensues almost immediately upon the receipt of a severe injury. (05 Mar 2000) |
| heat-shock factor | <cell biology, protein> A class of molecular chaperones found in both prokaryotes and in several compartments of eukaryotic cells. There is evidence that these proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures. (12 Dec 1998) Previous: heat-shock factor, heat-shock gene, heat-shock protein, heat-shock protein 27 kinaseNext: heat-shock proteins 90, heat-shock responseheat-shock factor -->heat-shock proteins 90 <cell biology, protein> A class of molecular chaperones whose members act in the mechanism of signal transduction by steroid receptors. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|